The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy

Mesenchymal stem cells (MSCs) have tumor-homing ability and play critical roles in tumor treatment, but their dual influences on tumor progression limit their therapeutic applications. Exosomes derived from MSCs (MSC-exosomes) exhibit great potential in targeted tumor treatment due to their advantag...

Full description

Bibliographic Details
Main Authors: Yilin Song, Quanlin Song, Daosheng Hu, Binwen Sun, Mingwei Gao, Xiangnan Liang, Boxin Qu, Lida Suo, Zeli Yin, Liming Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1299384/full
_version_ 1797366487160193024
author Yilin Song
Yilin Song
Yilin Song
Quanlin Song
Daosheng Hu
Daosheng Hu
Daosheng Hu
Binwen Sun
Binwen Sun
Binwen Sun
Mingwei Gao
Mingwei Gao
Mingwei Gao
Xiangnan Liang
Xiangnan Liang
Xiangnan Liang
Boxin Qu
Boxin Qu
Boxin Qu
Lida Suo
Lida Suo
Lida Suo
Zeli Yin
Zeli Yin
Zeli Yin
Liming Wang
Liming Wang
Liming Wang
author_facet Yilin Song
Yilin Song
Yilin Song
Quanlin Song
Daosheng Hu
Daosheng Hu
Daosheng Hu
Binwen Sun
Binwen Sun
Binwen Sun
Mingwei Gao
Mingwei Gao
Mingwei Gao
Xiangnan Liang
Xiangnan Liang
Xiangnan Liang
Boxin Qu
Boxin Qu
Boxin Qu
Lida Suo
Lida Suo
Lida Suo
Zeli Yin
Zeli Yin
Zeli Yin
Liming Wang
Liming Wang
Liming Wang
author_sort Yilin Song
collection DOAJ
description Mesenchymal stem cells (MSCs) have tumor-homing ability and play critical roles in tumor treatment, but their dual influences on tumor progression limit their therapeutic applications. Exosomes derived from MSCs (MSC-exosomes) exhibit great potential in targeted tumor treatment due to their advantages of high stability, low immunogenicity, good biocompatibility, long circulation time and homing characteristics. Furthermore, the artificial modification of MSC-exosomes could amplify their advantages and their inhibitory effect on tumors and could overcome the limit of tumor-promoting effect. In this review, we summarize the latest therapeutic strategies involving artificially modified MSC-exosomes in tumor treatment, including employing these exosomes as nanomaterials to carry noncoding RNAs or their inhibitors and anticancer drugs, and genetic engineering modification of MSC-exosomes. We also discuss the feasibility of utilizing artificially modified MSC-exosomes as an emerging cell-free method for tumor treatment and related challenges.
first_indexed 2024-03-08T17:05:50Z
format Article
id doaj.art-53923d11fb8245e8b350fd3024d5d49a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-08T17:05:50Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-53923d11fb8245e8b350fd3024d5d49a2024-01-04T05:06:37ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-01-011310.3389/fonc.2023.12993841299384The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapyYilin Song0Yilin Song1Yilin Song2Quanlin Song3Daosheng Hu4Daosheng Hu5Daosheng Hu6Binwen Sun7Binwen Sun8Binwen Sun9Mingwei Gao10Mingwei Gao11Mingwei Gao12Xiangnan Liang13Xiangnan Liang14Xiangnan Liang15Boxin Qu16Boxin Qu17Boxin Qu18Lida Suo19Lida Suo20Lida Suo21Zeli Yin22Zeli Yin23Zeli Yin24Liming Wang25Liming Wang26Liming Wang27Engineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaEngineering Technology Research Center for Translational Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaMesenchymal stem cells (MSCs) have tumor-homing ability and play critical roles in tumor treatment, but their dual influences on tumor progression limit their therapeutic applications. Exosomes derived from MSCs (MSC-exosomes) exhibit great potential in targeted tumor treatment due to their advantages of high stability, low immunogenicity, good biocompatibility, long circulation time and homing characteristics. Furthermore, the artificial modification of MSC-exosomes could amplify their advantages and their inhibitory effect on tumors and could overcome the limit of tumor-promoting effect. In this review, we summarize the latest therapeutic strategies involving artificially modified MSC-exosomes in tumor treatment, including employing these exosomes as nanomaterials to carry noncoding RNAs or their inhibitors and anticancer drugs, and genetic engineering modification of MSC-exosomes. We also discuss the feasibility of utilizing artificially modified MSC-exosomes as an emerging cell-free method for tumor treatment and related challenges.https://www.frontiersin.org/articles/10.3389/fonc.2023.1299384/fullmesenchymal stem cellsexosomestumor-targeted therapyanti-cancerdrug delivery
spellingShingle Yilin Song
Yilin Song
Yilin Song
Quanlin Song
Daosheng Hu
Daosheng Hu
Daosheng Hu
Binwen Sun
Binwen Sun
Binwen Sun
Mingwei Gao
Mingwei Gao
Mingwei Gao
Xiangnan Liang
Xiangnan Liang
Xiangnan Liang
Boxin Qu
Boxin Qu
Boxin Qu
Lida Suo
Lida Suo
Lida Suo
Zeli Yin
Zeli Yin
Zeli Yin
Liming Wang
Liming Wang
Liming Wang
The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy
Frontiers in Oncology
mesenchymal stem cells
exosomes
tumor-targeted therapy
anti-cancer
drug delivery
title The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy
title_full The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy
title_fullStr The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy
title_full_unstemmed The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy
title_short The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy
title_sort potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy
topic mesenchymal stem cells
exosomes
tumor-targeted therapy
anti-cancer
drug delivery
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1299384/full
work_keys_str_mv AT yilinsong thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT yilinsong thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT yilinsong thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT quanlinsong thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT daoshenghu thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT daoshenghu thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT daoshenghu thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT binwensun thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT binwensun thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT binwensun thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT mingweigao thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT mingweigao thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT mingweigao thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT xiangnanliang thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT xiangnanliang thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT xiangnanliang thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT boxinqu thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT boxinqu thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT boxinqu thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT lidasuo thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT lidasuo thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT lidasuo thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT zeliyin thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT zeliyin thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT zeliyin thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT limingwang thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT limingwang thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT limingwang thepotentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT yilinsong potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT yilinsong potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT yilinsong potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT quanlinsong potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT daoshenghu potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT daoshenghu potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT daoshenghu potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT binwensun potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT binwensun potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT binwensun potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT mingweigao potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT mingweigao potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT mingweigao potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT xiangnanliang potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT xiangnanliang potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT xiangnanliang potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT boxinqu potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT boxinqu potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT boxinqu potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT lidasuo potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT lidasuo potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT lidasuo potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT zeliyin potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT zeliyin potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT zeliyin potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT limingwang potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT limingwang potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy
AT limingwang potentialapplicationsofartificiallymodifiedexosomesderivedfrommesenchymalstemcellsintumortherapy